US weekly jobless claims came in at 215,000, dipping modestly from the prior week. The labour market remains healthy. That backdrop sets the stage for next week's Q2 earnings rush, with Bank of America, Johnson & Johnson, and UnitedHealth Group all due to report.
PepsiCo sent a warning shot today. The company flagged that tight consumer budgets are slowing US food and beverage demand. That signal matters beyond Pepsi alone. Consumer staples names face pressure if spending weakness persists.
Bears are piling into a handful of names. Alight is the week's most extreme case, with SI jumping to 134% of free float. Wolfspeed sits at 118% with zero shares available to borrow — any squeeze would be sharp.
CoreWeave added 5 points of short interest this week to reach 34% of free float. Bears are growing more aggressive against the AI infrastructure name despite its $37bn market cap.
InMode (INMD) drew a rival takeover bid from Steel Partners at $16.75 per share. Merger arbitrage activity is likely. Enovix shares climbed after the battery maker named a former Apple AirPods manufacturing leader as its new COO.
FT Markets reports that Teva and Polpharma Biologics struck a global licensing deal for a multiple sclerosis biosimilar targeting Roche's Ocrevus. London's IPO drought deepens — the value of bids for LSE companies now runs 27 times higher than new listings. Private equity firms TPG and Blackstone are seeking more than $4bn for a Hologic unit, signalling deal appetite at the top end of the market.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
